| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Financial Officer
1 company
Alexander A. Seelenberger last filed a Form 4 in August 2024, as See Remarks at VINC. Alexander A. Seelenberger's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 30,280 shares of VINC. Net of sales, the VINC filings show accumulation of 20,867 shares.
Alexander A. Seelenberger has 11 Form 4 filings on record from December 2020 to August 2024, all as Chief Financial Officer at Vincerx Pharma (VINC), 2020–2024.
The 24 reported transactions were 14 option or other derivative awards, 7 dispositions back to the company and 3 open-market purchases.
Counted by filing, the open-market trades come to 3 purchases worth about $135K and no sales.
The largest open-market purchase was 7,950 shares of VINC at an average $12.61 on June 29, 2021, about $100K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.